Vehreschild, Maria J. G. T.
Haverkamp, Miriam
Biehl, Lena M.
Lemmen, Sebastian
Fätkenheuer, Gerd
Article History
Received: 18 July 2018
Accepted: 21 August 2018
First Online: 3 September 2018
Compliance with ethical standards
:
: LMB has received lecture honoraria from Astellas and Merck/MSD, and travel grants from 3M and Gilead. MJGTV is a consultant to: Alb-Fils Kliniken GmbH, Arderypharm, Astellas Pharma, Berlin Chemie, DaVolterra, MaaT Pharma and Merck/MSD; has served at the speakers’ bureau of: Astellas Pharma, Basilea, Gilead Sciences, Merck/MSD, Organobalance, Pfizer; received research funding from: 3M, Astellas Pharma, DaVolterra, Gilead Sciences, MaaT Pharma, Merck/MSD, Morphochem, Organobalance, Seres Therapeutics.